32 Stem Cell Companies to Watch

The accompanying table below includes 32 companies in the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks with market caps below $250M. I will maintain the index with these 32 components and track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.

Below is a list of all 32 companies in descending order by market cap with a total value of $1.27B and an average stock price change of -15% over the past year for the index, as compared to losses of 20% for the Healthcare Sector SPDR (XLV), 4.7% for SPDR S&P Biotech (XBI), 9.1% for iShares Nasdaq Biotech (IBB), and 18.9% for PowerShares Biotech & Genome (PBE).


RTI Biologics (RTIX) – announced an $11.75M financing ($10M credit facility + $1.75M term loan) on Monday to replace its previous line of credit and supplement the Company's working capital needs.
Cytori Therapeutics (CYTX) – commenced patient enrollment last week in an investigator-initiated 10-patient study using adipose-derived stem cells processed by Cytori's Celution 800 System to treat stress urinary incontinence.
BioTime (BTIM) – biggest stock gain in past year (up over 700%)
ThermoGenesis (KOOL) – will report its fiscal 2Q09 results today with a conference call after the market close at 5 pm (ET).
Bioheart (BHRT) – up over 20% today on news of a grant-funded study in Italy for the Bioheart A&C Bio Science Twin-Pulsatile Life Support System which is expected to be completed within just 45 days with the potential for $2.1M in contract sales if results are positive.

StemCells (STEM)
BioMimetic Therapeutics (BMTI)

Osteotech (OSTE)
Neuralstem (CUR)
RegeneRx Biopharma (RGN) Athersys (ATHX)
Advanced Cell Technology (ACTC)
International Stem Cell Corp (ISCO)

Aastrom Biosciences (ASTM)
Mesoblast (MBLTY.PK)
Pluristem Therapeutics (PSTI)
HepaLife Technologies (HPLF)
Stem Cell Innovations (SCLL)
Isolagen (ILE)
CellCyte Genetics Corp (CCYG)
Cryo-Cell (CCEL.OB)
Stem Cell Therapeutics [SCTPF]
Brainstorm Cell Therapeutics [BCLI]
Stem Cell Authority [SCAL]
Opexa Therapeutics (OPXA)
Neostem (NBS)
Bio-Matrix Scientific Group [BMSN]
Cord Blood America (CBAI.OB)
MediStem [MEDS]
Stem Cell Therapy Internt'l [SCII]
MultiCell Technologies [MCET]
LifeStem International [LSTM]

[click to enlarge]

Comments

[rlwinvestor:]

This is definitely a hot sector, but I think the real money to be made is in the microcaps like CBAI.OB and ACTC.PK. Check out this great stem cell company trading blog: tradingstemcells2009.b.../

Feb 04 08:23 AM

[onewon:]

Are you kidding me???!!@!

STEM is the last of the bottom of the list!

so much debt, so little income no cash!

Feb 04 07:10 PM

[wilpal:]

STEM will start going sideways for the 3 months.
we may have a chance to get it @ 1.50


On Feb 04 10:11 AM Vincent Hearne wrote:

> LISTEN UP PEOPLE THIS ONE IS GOING TO GO BALLISTIC!!!!
>
> I hope you all haven't spent the money we made in
> the FNM FRE MER GS PUTS, SWING TRADING
> PROFITS IN KONG SCON CNTF and CTEL from 07
> because I'M BACK and we have work to do and
> money to make in the administration change of
> the LAME DUCK....KING GEORGE II.......................
>
>
> SELL 1/2 of any losing stock in your porfolio, sell your 3rd and
> second homes
> and buy as many shares of STEM as possible*****THIS IS A CHANCE of
>
> a LIFETIME that doesn't present itself but only once in a hundred
> years***
> THIS IS THE STEM CELL NATION and the HEALING will begin.
> 1.5 million news letters,emails
> and instant messages will be sent
> to accredited investors world-wide
> within the next week!
>
> STEMCELLS inc.
> out of PALO ALTO California aka "STEM VALLEY"
>
> STEM last sale 1.15 on the Nasdaq
>
> The 2000 short squeeze run-up to 23 dollars a share will look like
>
> a flat line on the 20 year linear chart as this stock
> is going to go completely PARABOLIC with a sling-
> shot style move surpassing all time highs in a single
> trading day once the news is released.
> =0 A
> 80 million shares outstanding and shrinking due to
> the accumulation of shares by fund managers,
> market makers , short-covering, technical trade
> imbalances , celebrities, and buy stops being elected
> imminent!
>
> ****STEM FAST FACTS*******
>
> STEM CELLS INC. has been diligently conducting research
> in STANFORD UNIVERSITY for the 8 years that the SCIENCE
> has been OUTLAWED by the BUSH ADMINISTRATION.*
>
> Dr. Wiessman has been using state appropriated funds by
> Arnold Swarzenegger's Proposition 71 money to jump-start STEM CELLS
> INC.
> ahead of the pack working on cures for BLINDNESS, INFANT BATTEN's
> DISEASE,
> ALZHEIMERS, DIABETES, BREAST CANCER, AMONGST OTHERS*
> ( a % of the 3 billion a year doled out to CALIFORNIA STEM CELL COMPANIES)
>
>
> A short interest has ballooned since the 20 million dollar financing
> accomplished last
> month leaving STEM extremely vulnerable to a short squeeze with any
> news release
> containing a scientific breakthrough, the acquisition of a key employee,
> or any hint of
> how there business model will work once they decide on what disease
> they will
> focus on first to market their stem-cell shots.*
>
> There is a wide-spread opinion that an 800 pound gorilla in the pharmaceutical
> industry
> is scooping up shares of STEM in the open market in order to reap
> the benefits of the
> incoming administration and their different stance on STEM CELL RESEARCH**
>
> While we have not expected Obama to have a liberal stance and he
> will reveal himself
> as deviating more to the center like Bill Clinton, this certainly
> will be a TREMENDOUS
> BOOST as DR.s OBAMA and CLINTON will provide the defibrillation to
> the beaten
> down industry in the form of EXECUTIVE ORDERS, FEDERAL GRANTS, and
> co-operation
> with the NATIONAL INSTITUTE of HEALTH***
>
> Already we are getting reports of major buyers stepping in
> such as Carl Icahn, T Boone Pickens, Oprah, and the fund
> managers of DIREXION and ULTRA PRO SHARES*****
>
>
> OKOKOKOK O LISTEN UP INVESTORS TRADERS
> MARKET MAKERS AND HEDGIES!!!!!!!!! I NEED YOUR
> ATTENTION RIGHT NOW!!!RIGHT NOW
>
>
>
> ITS ME AGAIN!!!!!your ABSOLUTE DEAD ON STOCK JOCKEY
> VINCENT HEARNE who combines TRADING FLOOR EXPERTISE
> with FUNDAMENTAL and TECHNICAL ANALYSIS as well as
> streamlining WALL STREET CAVEATS from the
> most informative sources...I try to get back to everyone who
> contacts me as the emails get into the thousands...IT is
> a rare phenomona when I swing and miss in the equities
> arena it just doesn't HAPPEN...
>
>
> YOU MUST UNDERSTAND THAT WHEN I HIT THE BANK
> with a MONSTER STOCK it is difficult to get back to everyone*
> this is my disclaimer as the money you will make may change
> your life forever.**
>
> MAJOR FUNDS ARE SHORTING PFE MRK GS MA
> to buy STEM!!BLUE HORSESHOE LOVES STEM!!!
> BLUEHORSESHOE hasn't loved STEM since 2000!

Feb 04 08:58 PM

[PeteK:]

Americans have no patience to wait.
We all know that.
5 to 10 years ?
No way.

Feb 05 04:49 AM

[whisperonth...:]

Any time someone (anyone) tries to tell me this or that stock is the hottest, best, most likely to succeed, I know it's time to sell mine if I have it, and run away from it if I don't. Sure, I may never be rich that way, but I've lost enough money on this junk to last me a lifetime. Other "hottest, best, most likely..." stocks sounded great, innovative, and profitable too. But usually it's just someone who bought a lot of stock on a stupid hunch and if they get you to buy more, they can sell theirs for a profit. Why else do we see the huge (in perspective) spikes in price matched with the huge drops immediately afterward? So no thank you. Maybe they won't be able to save me if I get really sick, but I'll have money to leave to my kids, and that's just as good.

Feb 05 08:19 AM

[bertil:]

You're absolutely right there "whisper..."! Snake oil comes in so many forms. The obvious thing is that stem cell research (and much other futuristic R & D) does need funding and investors and Short term speculation can be very hurtful and slow or stop progress.
My humble thought is; if you like the concept or possibility of f. ex. "stem cell" wait till the hustlers are hoarse and your temptation to make quick money cools off.... then realize biotech is a bucking broncho.

Feb 05 08:51 AM

[Whippet:]

I wish there were an ETF with this portfolio that I could short it on a continual basis... with a solid hedge against short-term upside jumps, it's easy money. These companies will dilute, dilute, dilute for 10+ years until there is even a remote possibility of FDA approval. It takes 5-7 years for a monoclonal antibody project to go from IND to BLA, and there is a well-established pathway here that Rituxan, Avastin, Campath, Remicade, etc. have followed. If antibodies, simple by comparison, are so full of clinical uncertainty and even safety problems (Tysabri, for instance), to think stem cells would be anything but a NIGHTMARE to get through a regulatory approval process is overly optimistic. Then there's the moral/ethical side of the equation...

Feb 05 11:30 AM

[H.J. Huneycutt:]

Stem cell research is no "hotter" than it was four months ago. It's just that irrationalism has gripped the market in the meantime based on the faulty assumption that the Obama Administration is magically going to make every struggling stem cell research company profitable.

I haven't looked at all 32 of the companies listed, but I'm willing to wager that more of these are great short candidates than long candidates right now.

Feb 05 12:03 PM

[Vincent Hearne:]

STEM CELLS INC bullish PENNANT formation
there is no stronger buy signal in money flows

Feb 07 07:17 PM

[World Marke...:]

Great Article, Interesting piece at
www.worldmarketmedia.c...

Talks about how Obama latest talks are affecting the Stem Cell Research

Sep 16 10:23 AM